Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19.
Indian J Ophthalmol
; 70(8): 3134-3136, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-2055711
ABSTRACT
This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and no other factor that could lead to the findings on his examinations. After treatment with high doses of topic, oral, and sub-conjunctival corticoids, the patient had a favorable therapeutic response. The signs of corneal transplant rejection must be oriented to the patients and the causing factors actively searched by ophthalmologists so that treatment is rapidly initiated and sequels are avoided. This report raises the question if these events are correlated and whether the patient should receive the second dose of the vaccine against SARS-CoV-2 or not.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Corneal Transplantation
/
COVID-19
/
BNT162 Vaccine
/
Graft Rejection
Type of study:
Case report
/
Observational study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Indian J Ophthalmol
Year:
2022
Document Type:
Article
Affiliation country:
Ijo.IJO_1021_22
Similar
MEDLINE
...
LILACS
LIS